These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9782737)

  • 1. [Changes in saccades in endocrine orbitopathy. Clarification of the contribution by H. D. Schworm et al. "Functional eye muscle changes in endocrine orbitopathy"].
    Schworm HD; Heufelder AE; Bötzel K; Leikam B; Beicht L; Boergen KP
    Ophthalmologe; 1998 Aug; 95(8):578-80. PubMed ID: 9782737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional eye muscle changes in endocrine orbitopathy].
    Schworm HD; Heufelder AE; Bötzel K; Leikam B; Beicht L; Boergen KP
    Ophthalmologe; 1997 Apr; 94(4):290-4. PubMed ID: 9229499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a relationship between the degree of preoperative motility impairment or the muscle thickness and the outcome of strabismus surgery in patients with graves' orbitopathy after decompression surgery?
    Pitz S; Esch A; Müller-Forell WS; Kahaly G; Mann W; Pfeiffer N
    Orbit; 2005 Sep; 24(3):173-6. PubMed ID: 16169802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measuring saccades in endocrine orbitopathy].
    Schworm HD; Buser A; Bötzel K; Heufelder AE; Leikam B; Boergen KP
    Ophthalmologe; 1997 Mar; 94(3):211-6. PubMed ID: 9181838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid orbitopathy: an update.
    Hodes BL; Frazee L; Szmyd S
    Ophthalmic Surg; 1979 Nov; 10(11):25-33. PubMed ID: 583294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of saccade analysis in early active Graves' ophthalmopathy.
    Schworm HD; Heufelder AE; Kunze A; Welge E; Boergen KP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1710-8. PubMed ID: 10845590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report: saccade analysis in acute Graves' ophthalmopathy.
    Schworm HD; Boergen KP
    Strabismus; 2000 Sep; 8(3):179-85. PubMed ID: 11035560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of ocular motility following modified 3-wall decompression of the orbita in endocrine orbitopathy for functional and rehabilitative indication].
    Grenzebach UH; Schnorbus U; Büchner T; Busse H; Stoll W
    Klin Monbl Augenheilkd; 2003 May; 220(5):345-51. PubMed ID: 12766824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electromyographic study of endocrine oculomotor deficiency].
    Reny A; Brichet B; Raspiller A
    Bull Soc Ophtalmol Fr; 1972 Jan; 72(1):101-6. PubMed ID: 4677974
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual motility impairment in endocrine orbitopathy.
    Mühlendyck H
    Dev Ophthalmol; 1989; 20():13-27. PubMed ID: 2591623
    [No Abstract]   [Full Text] [Related]  

  • 11. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
    Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute superior oblique palsy in monkeys: II. Changes in dynamic properties during vertical saccades.
    Shan X; Ying HS; Tian J; Quaia C; Walker MF; Optican LM; Tamargo RJ; Zee DS
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2612-20. PubMed ID: 17525191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine orbitopathy: a comparison of computerized tomographic results and orthoptic findings].
    Hilbertz T; Markl A; Pickardt CR; Boergen KP
    Rofo; 1988 Apr; 148(4):426-30. PubMed ID: 2834791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrine orbitopathy and significance of autoantibodies against 1D protein].
    Hrdá P; Sterzl I; Vána S; Novák Z; Matucha P; Kromminga A
    Cas Lek Cesk; 2007; 146(3):273-7. PubMed ID: 17419313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar influence in oculomotor phase-transition behavior.
    Joiner WM; Shelhamer M; Ying SH
    Ann N Y Acad Sci; 2005 Apr; 1039():536-9. PubMed ID: 15827017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular motor indicators of executive dysfunction in fragile X and Turner syndromes.
    Lasker AG; Mazzocco MM; Zee DS
    Brain Cogn; 2007 Apr; 63(3):203-20. PubMed ID: 17107741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Signs and symptoms of endocrine orbitopathy (author's transl)].
    Herzau V
    Klin Monbl Augenheilkd; 1976 Aug; 169(2):226-30. PubMed ID: 979046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Graves-Basedow disease on the function of oculomotor muscles].
    Rejnowicz-Krajewska L
    Klin Oczna; 1976 Jul; 46(7):783-9. PubMed ID: 989145
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of endocrine ophthalmopathy with saccadic eye movements.
    Mauri L; Meienberg O; Roth E; König MP
    J Neurol; 1984; 231(4):182-7. PubMed ID: 6549027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye muscle force development in thyroid-associated ophthalmopathy in different stages of disease.
    Tian S; Bolzani R; Benassi M; Lennerstrand G
    Acta Ophthalmol Scand; 2007 Jun; 85(4):431-7. PubMed ID: 17559468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.